CHSY1: Chondroitin Sulfate Synthase 1

Key enzyme in glycosaminoglycan biosynthesis and skeletal development

Gene Information Card

Symbol CHSY1
Full Name Chondroitin Sulfate Synthase 1
Gene Type Protein coding
Chromosomal Location 15q26.3
NCBI Gene ID 22856 ncbi.nlm.nih.gov/gene/22856
Ensembl ID ENSG00000137807
UniProt ID Q86X52
OMIM ID 608183
HGNC ID 18898
Aliases CHSY, CHSY-1, CSS1, KIAA0990

Description

CHSY1 encodes chondroitin sulfate synthase 1, a transmembrane glycosyltransferase involved in the biosynthesis of chondroitin sulfate, a major component of the extracellular matrix. The enzyme catalyzes the polymerization of chondroitin sulfate chains by transferring glucuronic acid and N-acetylgalactosamine residues. CHSY1 is essential for normal skeletal development, and its loss-of-function mutations cause Temtamy preaxial brachydactyly syndrome, characterized by limb malformations and intellectual disability.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Temtamy preaxial brachydactyly syndrome Loss-of-function mutations in CHSY1 impair chondroitin sulfate synthesis, disrupting extracellular matrix signaling during limb development. OMIM #605282; multiple families with homozygous or compound heterozygous mutations
Skeletal dysplasia with intellectual disability Reduced chondroitin sulfate chain elongation affects cartilage and bone formation. Case reports in ClinVar and literature (Li et al., 2010)

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Heart 8.3 Low
Liver 3.1 Low
Kidney 6.7 Low
Lung 5.9 Low
Skeletal muscle 4.2 Low
Placenta 15.8 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 18.2 Embryonic kidney cells; high expression
HeLa 9.5 Cervical cancer cells; moderate expression
HepG2 4.1 Hepatocellular carcinoma; low expression
K562 2.3 Leukemia cells; very low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1019G>A (p.Arg340Gln) Missense Rare Loss of enzymatic activity; associated with Temtamy syndrome
c.1435C>T (p.Arg479*) Nonsense Rare Premature truncation; loss of function
c.1666_1667del (p.Leu556Glufs*12) Frameshift Rare Loss of function; reported in ClinVar
Mutation functional classification

Loss of Function (LOF)

Most CHSY1 disease-associated mutations are loss-of-function, leading to reduced chondroitin sulfate synthesis and skeletal defects.

Gain of Function (GOF)

No gain-of-function mutations reported in CHSY1.

Dominant Negative (DN)

No dominant-negative mutations described; inheritance is autosomal recessive.

Gene Ontology (GO)

galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity (GO:0015018) glucuronosyltransferase activity (GO:0015020)
acetylglucosaminyltransferase activity (GO:0008375) • chondroitin sulfate biosynthetic process (GO:0030206)
Golgi apparatus (GO:0005794) • integral component of membrane (GO:0016021)

Pathways

Chondroitin sulfate / dermatan sulfate biosynthesis (Reactome: R-HSA-1971475)
Glycosaminoglycan metabolism (KEGG: hsa00532)

Protein Summary

CHSY1 is a 759-amino acid type II transmembrane protein localized to the Golgi apparatus. It possesses dual glycosyltransferase activities: glucuronyltransferase and N-acetylgalactosaminyltransferase, enabling the elongation of chondroitin sulfate chains. The protein contains a short N-terminal cytoplasmic domain, a transmembrane domain, and a large luminal catalytic domain. Mutations that disrupt its catalytic activity lead to impaired chondroitin sulfate synthesis, resulting in skeletal abnormalities and neurodevelopmental deficits.

Related Products

Product name Cat.No. Species Gene ID
CHSY1 Knockout HEK293 Cell Line EDJ-KQ7697 Human 22856 Details Get a Quote
CHSY1 Knockout A-549 Cell Line EDJ-KQ33073 Human 22856 Details Get a Quote
CHSY1 Knockout HCT 116 Cell Line EDJ-KQ33074 Human 22856 Details Get a Quote
CHSY1 Knockout HeLa Cell Line EDJ-KQ33075 Human 22856 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: